A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...
A small semaglutide trial suggests the medicine's suppression of appetite may extend to alcohol, but larger tests are needed ...
The Crisis Center of Tampa Bay launched a free week-long program that medically assists overdose patients while they detox ...
The percentage of patients receiving medication for opioid use disorder in federally qualified health centers increased from 2017 to 2023.
LICADD has been addressing substance use for nearly 70 years, but that fight is not stopping, nor is it's intensity lessening ...
Although the prevalence of substance use disorder increased during the COVID-19 pandemic, the receipt of treatment declined ...
After nearly a decade of annual upticks in overdose deaths, the city saw a drop in 2023, the latest data available. Something ...
When prescribing opioids for acute pain, physicians should be attentive to a patient’s individual risk factors, according to ...
The medications “help to bridge that gap between 'I want to get clean' and getting clean," a prisons official said.
A good night's sleep often sets the stage for a positive day. But for the nearly quarter of American adults struggling with mental illness, a good ni ...
Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback